Lacatena M, Comes P, Argese A V, Leo S
Minerva Chir. 1989 Mar 31;44(6):1021-3.
A personal series of colo-rectal tumours from 1979 to 1987 has been examined so as to check the validity of CEA as a marker in the diagnosis of these tumours. The data confirmed what has already been reported, namely its poor diagnostic sensitivity even though its utility for prognosis and in the follow-up of these patients remains confirmed, as is shown by the literature.
对1979年至1987年期间的一系列个人结直肠肿瘤病例进行了检查，以验证癌胚抗原（CEA）作为这些肿瘤诊断标志物的有效性。数据证实了已有报道的内容，即尽管文献表明其对这些患者的预后评估及随访仍有作用，但它的诊断敏感性较差。
